CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Nerium Biotechnology Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Nerium Biotechnology Inc.
5886 DeZavala Rd
Ste 102 PMB 537
Phone: (210) 822-7908p:210 822-7908 San Antonio, TX  78249  United States Fax: (210) 561-0386f:210 561-0386
Filed for Bankruptcy on 7/9/2023
Case #23-50890, filed in the U.S. Bankruptcy Court for the Western District of Texas (San Antonio) (Chapter 7)
Business Summary
Nerium Biotechnology, Inc. (NBI) is a United States-based biotechnology company. It is a research and development company dedicated to offering solutions that are based on scientific research. The Company focused on developing natural botanical compounds for beneficial use by the consumer. The Company development of natural botanical products is founded on this continuing research at medical institutions using the scientific methods and technology.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202012/31/2019YesYesYes--

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer Dennis R.Knocke 12/1/2020 1/17/2007
Chief Financial Officer Henry C.Bourg
Executive Vice President and Sec-Treasurer Joseph B.Nester 12/1/2020 3/1/2007
Chief Agricultural Officer Joel E.Curtis
Director Gustavo A.Ulloa 1/17/2007 1/17/2007

Business Names
Business Name
Agellum, LLC
Drogueria Salud Integral S. de R.L.
Farmacia Salud Integral, S. de R.L.
13 additional Business Names available in full report.

General Information
Outstanding Shares: 36,469,181 (As of 9/30/2020)
Federal Tax Id: 141987900
Fax Number: (210) 561-0386


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, January 1, 2024